Related Experiment Video
Updated: Aug 13, 2025

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
Long Non-Coding RNA GAS5 Promotes BAX Expression by Competing with microRNA-128-3p in Response to 5-Fluorouracil
Heejin Lee1,2, Hoin Kang1, Chongtae Kim1
1Department of Biochemistry, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
Abstract:
The acquisition of drug resistance is a major hurdle for effective cancer treatment. Although several efforts have been made to overcome drug resistance, the underlying mechanisms have not been fully elucidated. This study investigated the role of long non-coding RNA (lncRNA) growth arrest-specific 5 (GAS5) in drug resistance. GAS5 was found to be downregulated in colon cancer cell lines that are resistant to 5-fluorouracil (5-FU). Downregulation of GAS5 decreased the viability of HCT116 cells and the level of the pro-apoptotic BAX protein, while GAS5 overexpression promoted cell death in response to 5-FU. The interaction between GAS5 and BAX mRNA was investigated using MS2-tagged RNA affinity purification (MS2-trap) followed by RT-qPCR, and the results showed that GAS5 bound to the 3'-untranslated region of BAX mRNA and enhanced its expression by interfering with the inhibitory effect of microRNA-128-3p, a negative regulator of BAX. In addition, ectopic expression of GAS5 increased the sensitivity of resistant cells in response to anti-cancer drugs. These results suggest that GAS5 promoted cell death by interfering with miR-128-3p-mediated BAX downregulation. Therefore, GAS5 overexpression in chemo-resistant cancer cells may be a potential strategy to improve the anti-cancer efficacy of drugs.
Insights
Long non-coding RNA GAS5 is downregulated in chemo-resistant colon cancer. Overexpressing GAS5 enhances anti-cancer drug efficacy by promoting apoptosis via BAX regulation.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Drug resistance is a significant challenge in cancer therapy.
- Mechanisms underlying cancer drug resistance require further elucidation.
- Long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in various cellular processes, including cancer progression and drug response.
Purpose of the Study:
- To investigate the role of lncRNA GAS5 in the development of chemoresistance in colon cancer.
- To elucidate the molecular mechanism by which GAS5 influences sensitivity to 5-fluorouracil (5-FU).
Main Methods:
- Analysis of GAS5 expression in 5-FU-resistant colon cancer cell lines.
- Assessment of cell viability and apoptosis markers (BAX) following GAS5 manipulation.
- MS2-trap assay combined with RT-qPCR to determine GAS5-mRNA interactions.
- Investigation of the regulatory relationship between GAS5, BAX, and microRNA-128-3p.
Main Results:
- GAS5 was significantly downregulated in 5-FU-resistant colon cancer cells.
- GAS5 downregulation reduced cell viability and BAX protein levels.
- GAS5 overexpression promoted 5-FU-induced cell death.
- GAS5 directly binds to the 3'-UTR of BAX mRNA, enhancing its expression by inhibiting miR-128-3p.
- Ectopic GAS5 expression resensitized resistant cells to anti-cancer drugs.
Conclusions:
- GAS5 plays a crucial role in overcoming 5-FU resistance in colon cancer.
- GAS5 promotes apoptosis and enhances chemo-sensitivity by modulating the miR-128-3p/BAX axis.
- GAS5 represents a potential therapeutic target for improving the efficacy of chemotherapy in resistant cancers.
Related Concept Videos
MicroRNAs
lncRNA - Long Non-coding RNAs
Transcriptional Regulation: Riboswitches
Types of RNA
RNA Performs Diverse...
Drugs that Stabilize Microtubules
RNA Splicing

